Regentis Biomaterials RGNT
NYSE RGNT
$1.50 +0.03 (+2.41%)
As of: Oct 21, 2026 · 3:51 PM EDT

Regentis Biomaterials (RGNT) Other Non-Current Liabilities (2024)

Updated

Regentis Biomaterials (RGNT) posted Other Non-Current Liabilities of $160,000 for Q4 2024.

Analysis

Regentis Biomaterials (RGNT) Other Non-Current Liabilities (2024) Analysis & Trends

  • In prior years, Regentis Biomaterials' Other Non-Current Liabilities was $623,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 Regentis Biomaterials 852,949.72 852,949.72 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 160,000.00
API Access

Regentis Biomaterials Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RGNT&period=max&api_key=YOUR_API_KEY